Over 301 million people globally and 19.1% of US adults (48.0 million) live with diagnosed anxiety disorders, with 42.0% of Gen Z experiencing severe symptoms and 63.1% of sufferers remaining completely untreated. Costing the US economy $124 billion annually in lost productivity and increasing cardiovascular disease risk by 35%, anxiety is the world’s most prevalent mental disorder, with CBT and mindfulness programs delivering up to 75% clinical recovery rates. The figures below come from empirical research published by the World Health Organization, NIMH, the ADAA, the APA, and JAMA Psychiatry.
TL;DR
- Over 301 million people globally live with a diagnosed anxiety disorder (WHO GBD Study)
- 19.1% of US adults (48.0 million people) experience an anxiety disorder annually (NIMH)
- 31.1% of US adults will experience an anxiety disorder at some point in their lifetime (Harvard)
- Women experience anxiety at nearly double the rate of men (23.4% women vs 14.3% men)
- 31.9% of US adolescents (ages 13-18) meet diagnostic criteria for an anxiety disorder (NIMH)
- Only 36.9% of individuals with anxiety receive professional mental health treatment (ADAA)
- 42.0% of Gen Z adults report experiencing moderate to severe daily anxiety (APA)
- 78.0% of adults identify cost of living and inflation as their primary anxiety triggers (Gallup)
- Anxiety disorders cost the US economy an estimated $124 billion per year (JCP / WHO)
- Untreated generalized anxiety results in 21.4 lost productive workdays per employee per year
- 50.0% to 60.0% of individuals with anxiety suffer from co-occurring clinical depression (ADAA)
- Chronic untreated anxiety increases long-term cardiovascular heart disease risk by +35.0%
- Cognitive Behavioral Therapy (CBT) achieves a 60.0% to 75.0% clinical recovery success rate
1. Global and US Prevalence: 301M Worldwide and Sex Disparities
Anxiety disorders constitute the single most prevalent class of psychiatric conditions across modern human populations. The World Health Organization (WHO) records over 301 million people globally living with diagnosed anxiety.
US prevalence is acute: 19.1% of US adults (48.0M people) experience anxiety annually (NIMH), with women exhibiting nearly double the rate of men (23.4% vs 14.3%), while 63.1% of sufferers receive zero professional treatment.
| Metric | Value | Source |
|---|---|---|
| Global population living with a diagnosed anxiety disorder (world’s most common mental disorder) | 301M+ people globally (4.05% of world population) | World Health Organization (WHO) Global Burden of Disease |
| US adult population experiencing an anxiety disorder in the past year | 19.1% of adults (approx 48.0M adults) | National Institute of Mental Health (NIMH) |
| US adult lifetime prevalence of any anxiety disorder | 31.1% of adults | NIMH / Harvard Medical School NCS-R |
| Women vs men anxiety prevalence ratio in the US | 23.4% women vs 14.3% men (nearly 2x higher for women) | NIMH Epidemiology |
| Adolescents (ages 13-18) in the US diagnosed with an anxiety disorder | 31.9% of teenagers | NIMH / CDC YRBSS |
| Adults receiving professional mental health treatment among those with diagnosed anxiety | 36.9% receive treatment (63.1% untreated) | Anxiety and Depression Association of America (ADAA) |
Neurological meditation practices connect to our meditation statistics. Source: NIMH Anxiety Statistics.
2. Clinical Subtypes: Social Anxiety, GAD, Phobias, and Panic
Anxiety manifests across distinct clinical presentations defined by specific environmental triggers and somatic mechanisms. NIMH data reveals that Specific Phobias affect 19.3 million US adults (9.1%), while Social Anxiety affects 15.0 million (7.1%).
Chronic tension is pervasive: Generalized Anxiety Disorder (GAD) impacts 6.8 million adults, Post-Traumatic Stress Disorder (PTSD) affects 7.7 million, and Panic Disorder affects 6.0 million.
| Metric | Value | Source |
|---|---|---|
| Generalized Anxiety Disorder (GAD) annual US adult prevalence | 3.1% (6.8M adults) | ADAA / NIMH |
| Social Anxiety Disorder (Social Phobia) annual US adult prevalence | 7.1% (15.0M adults) | NIMH Social Anxiety Data |
| Specific Phobias (animals, heights, medical) annual US adult prevalence | 9.1% (19.3M adults) | NIMH Phobia Statistics |
| Panic Disorder annual US adult prevalence | 2.7% (6.0M adults) | ADAA Facts & Statistics |
| Post-Traumatic Stress Disorder (PTSD) annual US adult prevalence | 3.6% (7.7M adults) | NIMH PTSD Data |
| Obsessive-Compulsive Disorder (OCD) annual US adult prevalence | 1.2% (2.5M adults) | International OCD Foundation (IOCDF) |
Sleep architecture correlations connect to our sleep statistics. Source: ADAA Facts & Statistics.
3. The Youth Crisis: 42% Gen Z Anxiety and Macroeconomic Stressors
Young adults and adolescents experience unprecedented levels of chronic stress and environmental uncertainty. The American Psychological Association (APA) reports that 42.0% of Gen Z adults experience moderate to severe daily anxiety.
Economic pressures dominate: 78.0% of adults cite inflation and housing affordability as primary anxiety drivers (Gallup), while 66.0% report distress over political division and 48.0% suffer from climate eco-anxiety.
| Metric | Value | Source |
|---|---|---|
| Gen Z (ages 18-27) reporting moderate to severe daily symptoms of anxiety | 42.0% of Gen Z | American Psychological Association (APA) Stress in America |
| Millennials reporting moderate to severe daily anxiety | 34.0% | APA Stress in America |
| Adults citing economic inflation, cost of living, and housing as primary anxiety drivers | 78.0% | Gallup National Health & Well-Being Index |
| Adults citing global conflicts and political polarization as major sources of anxiety | 66.0% | APA Survey |
| Adults citing climate change anxiety (‘eco-anxiety’) | 48.0% of young adults | The Lancet Planetary Health |
Digital screen habits connect to our social media mental health statistics. Source: APA Stress in America.
4. Workplace Productivity and the $124 Billion Economic Burden
Unmanaged anxiety exacts an enormous financial toll on enterprise productivity and healthcare systems. The Journal of Clinical Psychiatry calculates the annual US economic burden of anxiety at $124 billion.
Workforce friction is substantial: untreated anxiety results in 21.4 lost productive workdays per affected employee annually (WHO), driving 64.0% of Fortune 500 corporations to deploy digital mental health benefits (Lyra, Spring Health).
| Metric | Value | Source |
|---|---|---|
| Annual economic cost of anxiety disorders to the US economy (healthcare + lost workplace productivity) | $124B per year | Journal of Clinical Psychiatry / WHO |
| Lost workplace productive days per employee suffering from untreated generalized anxiety annually | 21.4 lost days/year | World Health Organization (WHO) |
| Employees reporting anxiety has negatively impacted their job performance or career advancement | 56.0% | Mental Health America (MHA) Workplace Report |
| Fortune 500 companies offering free employee mental health coaching apps (Lyra, Spring Health) | 64.0% | Business Group on Health |
Professional workplace stress connects to our workplace burnout statistics. Source: World Health Organization.
5. Somatic Health Risks: Depression Comorbidity and Heart Disease
Chronic sympathetic nervous system activation exerts severe long-term physiological tolls on physical health. The ADAA documents a 50.0% to 60.0% comorbidity rate between anxiety disorders and Major Depression.
Somatic risks compound: the American Heart Association (AHA) links chronic untreated anxiety with a 35.0% higher risk of cardiovascular disease, while 44.0% of patients experience chronic gastrointestinal IBS symptoms.
| Metric | Value | Source |
|---|---|---|
| Anxiety patients who also meet clinical diagnostic criteria for Major Depressive Disorder | 50.0% to 60.0% comorbidity | ADAA / Lancet Psychiatry |
| Individuals with chronic anxiety disorders who experience severe gastrointestinal IBS symptoms | 44.0% | Gastroenterology / Rome Foundation |
| Cardiovascular disease risk increase associated with long-term untreated chronic anxiety | +35.0% higher heart disease risk | American Heart Association (AHA) Circulation |
Generational office dynamics connect to our gen z workplace statistics. Source: American Heart Association Circulation.
6. Treatment Efficacy: Cognitive Behavioral Therapy and Mindfulness
Evidence-based psychotherapy and neurological self-regulation achieve high rates of clinical symptom remission. Cochrane Systematic Reviews document a 60.0% to 75.0% success rate for Cognitive Behavioral Therapy (CBT).
Teletherapy broadens access: 48.0% of anxiety patients use virtual care platforms (ATA), while clinical trials in JAMA Psychiatry proved 8-week Mindfulness-Based Stress Reduction (MBSR) programs equal the efficacy of standard SSRI medications.
| Metric | Value | Source |
|---|---|---|
| Clinical recovery/improvement rate for anxiety patients undergoing Cognitive Behavioral Therapy (CBT) | 60.0% to 75.0% CBT success rate | Cochrane Systematic Reviews / APA |
| Anxiety patients utilizing digital teletherapy and mobile mental health apps | 48.0% | American Telemedicine Association (ATA) |
| Mindfulness-Based Stress Reduction (MBSR) programs matching SSRI medication efficacy for anxiety | Equal efficacy in 8-week trials | JAMA Psychiatry (Hoge et al.) |
Summary: Anxiety by the Numbers
| Metric | Value | Primary Source |
|---|---|---|
| Global population with anxiety disorders | 301M+ people | WHO GBD Study |
| US adult past-year anxiety prevalence | 19.1% (48.0M adults) | NIMH Data |
| US adult lifetime anxiety prevalence | 31.1% of adults | NIMH / Harvard NCS-R |
| Female vs male anxiety rate in US | 23.4% vs 14.3% | NIMH Epidemiology |
| US adolescents with anxiety disorders | 31.9% of teens | NIMH / CDC YRBSS |
| Anxiety patients receiving treatment | 36.9% (63% untreated) | ADAA Facts |
| Social Anxiety Disorder US prevalence | 7.1% (15.0M adults) | NIMH Statistics |
| Gen Z adults reporting severe anxiety | 42.0% of Gen Z | APA Stress in America |
| Inflation/cost cited as top anxiety trigger | 78.0% | Gallup Health Index |
| US economic burden of anxiety | $124B/yr | J of Clinical Psychiatry |
| Lost workdays per untreated anxiety worker | 21.4 days/yr | WHO Global Health |
| Anxiety & depression comorbidity rate | 50% - 60% | ADAA / Lancet |
| Cardiovascular risk gain from anxiety | +35.0% higher risk | AHA Circulation |
| CBT clinical improvement success rate | 60% - 75% | Cochrane Reviews |
| Teletherapy adoption among anxiety patients | 48.0% | ATA Telemedicine |
| MBSR meditation matching SSRI efficacy | Equal efficacy | JAMA Psychiatry |
Methodology and Sources
The statistics in this report were compiled from international epidemiological surveys from the World Health Organization (WHO), psychiatric prevalence registries from the NIMH and Harvard NCS-R, diagnostic subtype benchmarks from the ADAA, stress trend indexes from the APA and Gallup, and clinical trial meta-analyses from Cochrane and JAMA Psychiatry.
-
World Health Organization (WHO): Global Burden of Disease Study & World Mental Health Report (global prevalence, lost workplace productivity, and treatment gaps).
-
National Institute of Mental Health (NIMH): Anxiety Disorders Epidemiology and Subtype Statistics (past-year prevalence, sex ratios, and lifetime incidence).
-
Anxiety and Depression Association of America (ADAA): Facts & Statistics on Anxiety Subtypes & Comorbidity (GAD, Social Anxiety, Panic Disorder, and treatment rates).
-
American Psychological Association (APA): Stress in America Annual National Survey (generational stress metrics, Gen Z anxiety, and macroeconomic drivers).
-
Journal of Clinical Psychiatry & JAMA Psychiatry: Economic Burden of Anxiety and MBSR vs. Escitalopram Trials (healthcare costs and mindfulness clinical trial benchmarks).
-
American Heart Association (AHA - Circulation): Psychological Health, Well-Being, and the Mind-Heart-Body Connection (cardiovascular disease comorbidity and somatic risks).
-
Data watch: Anxiety statistics reflect clinical diagnostic criteria based on DSM-5 and ICD-11 classifications (GAD, Social Anxiety, Panic, Phobias, PTSD, OCD). Informal self-described situational nervousness is excluded from epidemiological counts.
-
Last updated: August 2026. This roundup is updated quarterly as WHO global health datasets, NIMH surveillance updates, and psychiatric clinical trial findings are published.